BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22526164)

  • 21. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors.
    Ogura K; Mizowaki T; Ogura M; Sakanaka K; Arakawa Y; Miyamoto S; Hiraoka M
    J Neurooncol; 2012 Sep; 109(2):425-32. PubMed ID: 22714054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HFSRT of the resection cavity in patients with brain metastases.
    Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
    Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
    Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
    BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique.
    Kelly PJ; Lin YB; Yu AY; Alexander BM; Hacker F; Marcus KJ; Weiss SE
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):95-101. PubMed ID: 21168282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy.
    Croker J; Chua B; Bernard A; Allon M; Foote M
    Clin Exp Metastasis; 2016 Feb; 33(2):125-32. PubMed ID: 26482476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated stereotactic radiotherapy in five daily fractions for post-operative surgical cavities in brain metastases patients with and without prior whole brain radiation.
    Al-Omair A; Soliman H; Xu W; Karotki A; Mainprize T; Phan N; Das S; Keith J; Yeung R; Perry J; Tsao M; Sahgal A
    Technol Cancer Res Treat; 2013 Dec; 12(6):493-9. PubMed ID: 23617283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.
    Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):336-42. PubMed ID: 22652105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
    Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
    Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
    Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
    Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
    Prabhu R; Shu HK; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e61-6. PubMed ID: 22516387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
    Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
    Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis.
    Robbins JR; Ryu S; Kalkanis S; Cogan C; Rock J; Movsas B; Kim JH; Rosenblum M
    Neurosurgery; 2012 Nov; 71(5):937-43. PubMed ID: 22806080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cavity volume changes after surgery of a brain metastasis-consequences for stereotactic radiation therapy.
    Scharl S; Kirstein A; Kessel KA; Duma MN; Oechsner M; Straube C; Combs SE
    Strahlenther Onkol; 2019 Mar; 195(3):207-217. PubMed ID: 30386864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative stereotactic radiosurgery and hypofractionated radiotherapy for brain metastases using Gamma Knife and CyberKnife: a dual-center analysis.
    Kübler J; Wester-Ebbinghaus M; Wenz F; Stieler F; Bathen B; Mai SK; Wolff R; Hänggi D; Blanck O; Giordano FA
    J Neurosurg Sci; 2024 Feb; 68(1):22-30. PubMed ID: 32031357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
    Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
    J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.